Navigation Links
Cranberry-Active Proven to Treat and Prevent Vaginal Infections
Date:4/22/2013

AMSTERDAM, April 22, 2013 /PRNewswire/ --

Dutch Medical Brands receives first European Class IIa Medical Device Status to treat vaginal infections by using cranberry extracts

Instead of traditional treatment with antibiotics or chemical substances, vaginal infections can be treated and prevented by using Cranberry-Active tablets, developed by Dutch company Medical Brands. The company has obtained a European Class IIa Medical Device Status for its patented Cranberry-Active tablet, making it the first and only cranberry-based product in Europe which has a proven medical claim to treat and prevent vaginal infections.

After the successful introduction of Cranberry-Active capsules for the treatment of bladder- and urinary tract infections in 2012, Medical Brands and American company NATUREX-DBS together have introduced their latest development for treatments of vaginal infections.

,,Vaginal Infections are a serious health problem, affecting one of every three women during their lifetime," says Maikel Hendriks, president of Medical Brands. ,,After the first treatment, another 30 percent will suffer from re-occurrence within three months and 80 percent within nine months."

While the claims of other cranberry-based food supplements and pro-biotic vaginal products have been rejected by the European Food and Safety Authority (EFSA), Medical Brands produced studies which clinically showed that the Cranberry-Active treats and prevents vaginal infections. The product can be freely sold as a self-care medical device on the OTC market in all European countries.

Maikel Hendriks: ,,Our Cranberry-Active marketing authorization is the culmination of years of planning, development and clinical investigation. We answer to a growing global push towards safe and natural solutions as the resistance to antibiotics continues to rise."

His company is specialised in developing self-care medical devices without pharmacologic effects. It provides consumers with solutions for everyday diseases without the side effects that most drugs have.

In the Netherlands and Scandinavia the tablet is sold as the Vaginal Infection Tablet by 'i say'. In other countries Medical Brands is still searching for partners to distribute the products.


'/>"/>
SOURCE Medical Brands
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cranberry-Active démontre sa capacité à traiter et prévenir les infections vaginales
2. Cranberry-Active wirksam zur Behandlung und Vorbeugung vaginaler Infektionen
3. Cranberry Capsule Proven to Cure Bladder Infection
4. Nonin Medical Awarded Novation Contract for Clinically Proven Pulse Oximeters
5. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
6. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
7. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
8. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
9. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
10. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
11. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... OCEANSIDE, Calif. , Aug. 15, 2017  AOTI Inc. announced ... Advanced Oxygen Therapy Inc., has recently opened a New York City ... the ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ... approved by the Accreditation Commission for Health Care (ACHC) under the ... ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 million ... continuing operations Second-quarter 2017 ... million Second-quarter 2017 Sterile ... Second-quarter 2017 adjusted diluted earnings ... to $0.93 Second-quarter 2017 ...
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc (NASDAQ: ... agreements to resolve virtually all known U.S. mesh product ... to resolve the known remaining U.S. claims at reasonable ... beginning in the fourth quarter of 2017 and continuing ... its second quarter 2017 results, the Company intends to ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Paul Vitenas, MD, FACS , ... Top Doctor. The annual list identifies the nation’s top physicians, in a variety of ... it to the top of Castle Connolly’s coveted ranking. , Castle Connolly is the ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards of Infection ... reprocessing cycle, both between patient procedures and before storage, is a requisite practice ... important to the prevention of disease transmission and nosocomial infection as cleaning and ...
(Date:8/16/2017)... ... 16, 2017 , ... Richard Strawn’s new book Surgical ... of a cancer diagnosis, surgery and recovery, the Psalms provided encouragement and hope, ... God shows love to those who are sick., Surgical Psalms contains 36 reflections ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... an opportunity for men and women to train as hospice volunteers. Volunteers provide ... life-limiting illness. For over 30 years, the agency has trained volunteers to be ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... and marketers of high-quality anti-aging skincare solutions, recently announced the launch of two ... are an affordable, yet effective alternative to expensive plastic surgery or in-patient cosmetic ...
Breaking Medicine News(10 mins):